Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Fang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Emergency Medicine|August 22, 2022
Man With Finger UlcerationsAndrew Mittelman, Anna Fang, Laura Welsh
CNS Drugs|September 1, 2017
Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?Elyse Swallow, Anna Fang, James Signorovitch, et al.
JMIR Formative Research|October 1, 2024
Exploring Trade-Offs for Online Mental Health Matching: Agent-Based Modeling StudyYuhan Liu, Anna Fang, Glen Moriarty, et al.
Journal of Medical Economics|April 2, 2016
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysisNanxin Li, Yanni Hao, Valerie Koo, et al.
Current Medical Research and Opinion|December 15, 2015
Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the USNanxin Li, Yanni Hao, Andrew Kageleiry, et al.
Expert Opinion on Pharmacotherapy|April 8, 2016
Treatment patterns and factors associated with the use of everolimus among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims studyAnnie Guérin, Yanni Hao, Derek Tang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Emergency Medicine|August 22, 2022
Man With Finger UlcerationsAndrew Mittelman, Anna Fang, Laura Welsh
CNS Drugs|September 1, 2017
Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?Elyse Swallow, Anna Fang, James Signorovitch, et al.
JMIR Formative Research|October 1, 2024
Exploring Trade-Offs for Online Mental Health Matching: Agent-Based Modeling StudyYuhan Liu, Anna Fang, Glen Moriarty, et al.
Journal of Medical Economics|April 2, 2016
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysisNanxin Li, Yanni Hao, Valerie Koo, et al.
Current Medical Research and Opinion|December 15, 2015
Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the USNanxin Li, Yanni Hao, Andrew Kageleiry, et al.
Expert Opinion on Pharmacotherapy|April 8, 2016
Treatment patterns and factors associated with the use of everolimus among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims studyAnnie Guérin, Yanni Hao, Derek Tang, et al.
Pageof 1